• Press Release

Mount Sinai Scientist Recognized for Outstanding Basic Research Contributions to Neuropsychopharmacology

  • New York, NY
  • (December 09, 2019)

Scott Russo, PhD, Professor of Neuroscience and Director of the Center for Affective Neuroscience within the Nash Family Department of Neuroscience and The Friedman Brain Institute at Mount Sinai, has been awarded the 2019 Daniel H. Efron Research Award from the American College of Neuropsychopharmacology (ACNP). The award is given in recognition of outstanding basic research contributions to neuropsychopharmacology, the study of the neural mechanisms by which drugs affect behavior. Dr. Russo was presented the award at the 58th Annual Meeting of the ACNP in Orlando, Florida.

Dr. Russo is recognized internationally for his contributions to the understanding of neural and immunological mechanisms underlying neuropsychiatric disorders such as depression and anxiety. His translational studies of depression-like behaviors in rodent models have identified novel disease mechanisms in depressed humans. The Russo Lab at Mount Sinai uses a broad array of tools to gain insight into how the brain and body adapt to stress and how a failure in adaptation may result in pathological behaviors associated with depression and anxiety.

Over the past decade, Dr. Russo has made outstanding contributions to psychopharmacology and the molecular understanding of neuropsychiatric disease. He has received numerous honors and awards, which include the Johnson & Johnson/IMHRO Rising Star in Translational Research and being named a Kavil National Academy of Science Frontiers Fellow.

Dr. Russo is the latest in a long line of Mount Sinai winners of ACNP’s prestigious Efron Award, including:

  • Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System
  • Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System
  • Eric J. Nestler, MD, PhD, Dean for Academic and Scientific Affairs and Director of The Friedman Brain Institute
  • Joseph D. Buxbaum, PhD, Professor of Psychiatry, Genetics and Genomic Sciences, and Neuroscience, and Director of The Seaver Autism Center for Research and Treatment
  • Paul J. Kenny, PhD, Ward-Coleman Professor and Chair of the Nash Family Department of Neuroscience    

“This is testimony to the dominant role Mount Sinai has played in psychiatric neuroscience over a generation,” said Dr. Nestler. “Dr. Russo’s highly innovative and transformative research program is revealing fundamentally novel mechanisms of stress, depression, and resilience, and promises new treatments for several stress-related illnesses.” 

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.